|
|
Number of patients (n) |
Percentage (%) |
|
| Chemotherapy |
Docetaxel-Prednisone |
59 |
70.24 |
| Weekly used of Taxol |
6 |
7.14 |
|
| Estramustine acetate |
0 |
0 |
|
| Abiraterone acetate |
8 |
9.5 |
|
| Exclusively symptomatic treatment |
11 |
13.09 |
|
| Enzalutamide |
0 |
0 |
|
| Sipuleucel -T |
0 |
0 |
|
| Estrogens |
0 |
0 |
|
| Continuation of the previous androgen blockage treatment |
73 |
86.90 |
|
| Adjuvant therapy |
Biphosphonate |
59 |
70.23 |
| Daunosumab |
0 |
0 |
|
| RT Palliative |
3 |
3.57 |
|